ADM and glioblastoma: Furthermore, high ADM expression was significantly linked to poor prognosis in patients with LGG, LUAD, MESO, THYM, LIHC, HNSC, GBM, KICH, KIRP, CESC, PAAD, and STAD, while its negative influence on OS and RFS was validated in LUAD.